← Back to headlines
FDA Approves Updated Pfizer-BioNTech and Moderna COVID Vaccines for 2026–27 Season
The U.S. Food and Drug Administration has approved updated seasonal COVID-19 vaccines from Pfizer-BioNTech and Moderna for the 2026–2027 period. Both formulations have been specifically adapted to target the emerging XFG viral variant.
27 Aug, 20:30 — 27 Aug, 22:26
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (51/100)4 sources30/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center3
Center (3)
Reutersinvesting-comtaiwan-news
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 3 regions13/34
US2Intl1Taiwan1
Sources
Showing 4 of 4 sources
ReutersVery High6h ago
US FDA approves updated COVID vaccines for 2026-27 season - Reuters
US FDA approves updated COVID vaccines for 2026-27 season Reuters
Read full article →seeking-alphaMixed8h ago
Pfizer, BioNTech win approval for updated COVID-19 shot
Read full article →investing-com7h ago
US FDA approves updated COVID vaccines for 2026-27 season
By Reuters
Read full article →taiwan-newsMostly Factual8h ago
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine - Taiwan News
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine Taiwan News
Read full article →Coverage Timeline
First report: taiwan-news · 27 Aug, 20:30|Full coverage: 4 · 2h|Window: 2h
Left-leaningCenterRight-leaning
Related Stories
Markets Brace for Federal Reserve Policy Signals at Jackson Hole
18m ago
Trump Administration Proposes Restrictions on International Student Internships
40m ago
Nvidia Halts Revenue-Sharing Agreements With AI Cloud Providers
53m ago
US Nears Deal to Secure Long-Term Access to Venezuelan Oil Reserves
55m ago